Cargando…
Pricing and reimbursement of novel oncology drugs in Sweden
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Co-Action Publishing
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4865793/ https://www.ncbi.nlm.nih.gov/pubmed/27226841 http://dx.doi.org/10.3402/jmahp.v2.25925 |
_version_ | 1782431834438631424 |
---|---|
author | Haglund, Mattias Miller, Eric |
author_facet | Haglund, Mattias Miller, Eric |
author_sort | Haglund, Mattias |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-4865793 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Co-Action Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-48657932016-05-25 Pricing and reimbursement of novel oncology drugs in Sweden Haglund, Mattias Miller, Eric J Mark Access Health Policy Letter to the Editor Co-Action Publishing 2014-12-09 /pmc/articles/PMC4865793/ /pubmed/27226841 http://dx.doi.org/10.3402/jmahp.v2.25925 Text en © 2014 Mattias Haglund and Eric Miller http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution 4.0 International License, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for any purpose, even commercially, provided the original work is properly cited and states its license. |
spellingShingle | Letter to the Editor Haglund, Mattias Miller, Eric Pricing and reimbursement of novel oncology drugs in Sweden |
title | Pricing and reimbursement of novel oncology drugs in Sweden |
title_full | Pricing and reimbursement of novel oncology drugs in Sweden |
title_fullStr | Pricing and reimbursement of novel oncology drugs in Sweden |
title_full_unstemmed | Pricing and reimbursement of novel oncology drugs in Sweden |
title_short | Pricing and reimbursement of novel oncology drugs in Sweden |
title_sort | pricing and reimbursement of novel oncology drugs in sweden |
topic | Letter to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4865793/ https://www.ncbi.nlm.nih.gov/pubmed/27226841 http://dx.doi.org/10.3402/jmahp.v2.25925 |
work_keys_str_mv | AT haglundmattias pricingandreimbursementofnoveloncologydrugsinsweden AT millereric pricingandreimbursementofnoveloncologydrugsinsweden |